Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling

Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling

US Patent 9555032 · Granted Jan 31, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment for tau-related diseases2025
Urocortin 2 analogs and uses thereof2017
Cripto antagonism of activin and TGF-b signaling2017
Urocortin-III and uses thereof2016
Methods for increasing insulin secretion by co-stimulation of corticotropin-rele2016
Urocortin-III and uses thereof2014
Urocortin-III and uses thereof2013
Isolated nucleic acids encoding soluble corticotropin releasing factor receptor 2012
Urocortin-III and uses thereof2011
Urocortin proteins and uses thereof2011
Urocortin proteins and uses thereof2011
Antibodies to activin receptor2011